Hepatobiliary & Pancreatic Diseases International最新文献

筛选
英文 中文
Liver transplantation as an alternative for the treatment of non-resectable liver colorectal cancer: Advancing the therapeutic algorithm 肝移植作为治疗不可切除肝结直肠癌的替代方案:推进治疗算法
IF 3.3 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2023-12-30 DOI: 10.1016/j.hbpd.2023.12.002
Badi Rawashdeh , Richard Bell , Abdul Hakeem , Raj Prasad
{"title":"Liver transplantation as an alternative for the treatment of non-resectable liver colorectal cancer: Advancing the therapeutic algorithm","authors":"Badi Rawashdeh ,&nbsp;Richard Bell ,&nbsp;Abdul Hakeem ,&nbsp;Raj Prasad","doi":"10.1016/j.hbpd.2023.12.002","DOIUrl":"10.1016/j.hbpd.2023.12.002","url":null,"abstract":"<div><p>Colorectal cancer is a leading cause of cancer-related mortality, with nearly half of the affected patients developing liver metastases<span><span>. For three decades, liver resection (LR) has been the primary curative strategy, yet its applicability is limited to about 20% of cases. </span>Liver transplantation<span> (LT) for unresectable metastases<span><span> was attempted unsuccessfully in the 1990s, with high rates of perioperative death and recurrence. There is now more interest in this strategy due to improvements in systemic therapies and surgical techniques. A significant study conducted by the Oslo group showed that patients receiving liver transplants had a 60% chance of survival after five years. Significantly better results have been achieved by using advanced imaging for </span>risk stratification<span> and further refining selection criteria, especially in the Norvegian SECA trials. This review carefully charts the development and history of LT as a treatment option for colorectal cancer liver metastases. The revolutionary path from the early days of exploratory surgery to the current situation of cautious optimism is traced, highlighting the critical clinical developments and improved patient selection standards that have made LT a potentially curative treatment for such challenging very well selected cases.</span></span></span></span></p></div>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":"23 2","pages":"Pages 154-159"},"PeriodicalIF":3.3,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139061957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early-life exposure to gestational diabetes mellitus predisposes offspring to pediatric nonalcoholic fatty liver disease 早年妊娠糖尿病使后代易患小儿非酒精性脂肪肝
IF 3.3 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2023-12-30 DOI: 10.1016/j.hbpd.2023.12.007
Qian-Ren Zhang, Yan Dong, Jian-Gao Fan
{"title":"Early-life exposure to gestational diabetes mellitus predisposes offspring to pediatric nonalcoholic fatty liver disease","authors":"Qian-Ren Zhang, Yan Dong, Jian-Gao Fan","doi":"10.1016/j.hbpd.2023.12.007","DOIUrl":"https://doi.org/10.1016/j.hbpd.2023.12.007","url":null,"abstract":"<p>Nonalcoholic fatty liver disease (NAFLD) has emerged as the prevailing chronic liver disease in the pediatric population due to the global obesity pandemic. Evidence shows that prenatal and postnatal exposure to maternal abnormalities leads to a higher risk of pediatric NAFLD through persistent alterations in developmental programming. Gestational diabetes mellitus (GDM) is a hyperglycemic syndrome which has become the most prevalent complication in pregnant women. An increasing number of both epidemiologic investigations and animal model studies have validated adverse and long-term outcomes in offspring following GDM exposure <em>in utero</em>. Similarly, GDM is considered a crucial risk factor for pediatric NAFLD. This review aimed to summarize currently published studies concerning the inductive roles of GDM in offspring NAFLD development during childhood and adolescence. Dysregulations in hepatic lipid metabolism and gut microbiota in offspring, as well as dysfunctions in the placenta are potential factors in the pathogenesis of GDM-associated pediatric NAFLD. In addition, potentially effective interventions for GDM-associated offspring NAFLD are also discussed in this review. However, most of these therapeutic approaches still require further clinical research for validation.</p>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":"43 13 1","pages":""},"PeriodicalIF":3.3,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139061964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laparoscopic anatomic segmentectomy S8: Indocyanine green fluorescence approach and Glissonean approach (with videos) 腹腔镜解剖节段切除术 S8:吲哚菁绿荧光方法和格利索内方法(附视频)
IF 3.3 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2023-12-30 DOI: 10.1016/j.hbpd.2023.12.005
Feng Gao, Jun-Jun Jia, Jun-Fang Deng, Zhou Shao, Shu-Sen Zheng
{"title":"Laparoscopic anatomic segmentectomy S8: Indocyanine green fluorescence approach and Glissonean approach (with videos)","authors":"Feng Gao, Jun-Jun Jia, Jun-Fang Deng, Zhou Shao, Shu-Sen Zheng","doi":"10.1016/j.hbpd.2023.12.005","DOIUrl":"https://doi.org/10.1016/j.hbpd.2023.12.005","url":null,"abstract":"Abstract not available","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":"259 1","pages":""},"PeriodicalIF":3.3,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139061918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver transplantation and liver resection as alternative treatments for primary hepatobiliary and secondary liver tumors: Competitors or allies? 肝移植作为原发性肝胆肿瘤和继发性肝肿瘤的替代治疗方法:竞争对手还是盟友?
IF 3.3 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2023-12-30 DOI: 10.1016/j.hbpd.2023.12.001
Jan Lerut
{"title":"Liver transplantation and liver resection as alternative treatments for primary hepatobiliary and secondary liver tumors: Competitors or allies?","authors":"Jan Lerut","doi":"10.1016/j.hbpd.2023.12.001","DOIUrl":"10.1016/j.hbpd.2023.12.001","url":null,"abstract":"","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":"23 2","pages":"Pages 111-116"},"PeriodicalIF":3.3,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139061905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score 不同病因慢性肝病患者肝细胞癌检测模型之间的比较:ASAP 评分与 GALAD 评分
IF 3.3 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2023-12-30 DOI: 10.1016/j.hbpd.2023.12.004
Li-Yang Sun, Nan-Ya Wang, Yong-Kang Diao, Cun-Lin Yan, Zhu-Ping Fan, Lian-Hua Wei, Hui-Jun Li, Ming-Cheng Guan, Ming-Da Wang, Timothy M Pawlik, Wan-Yee Lau, Feng Shen, Guo-Yue Lv, Tian Yang
{"title":"Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score","authors":"Li-Yang Sun, Nan-Ya Wang, Yong-Kang Diao, Cun-Lin Yan, Zhu-Ping Fan, Lian-Hua Wei, Hui-Jun Li, Ming-Cheng Guan, Ming-Da Wang, Timothy M Pawlik, Wan-Yee Lau, Feng Shen, Guo-Yue Lv, Tian Yang","doi":"10.1016/j.hbpd.2023.12.004","DOIUrl":"https://doi.org/10.1016/j.hbpd.2023.12.004","url":null,"abstract":"<h3>Background</h3><p>Diagnostic panels based on multiple biomarkers and clinical characteristics are considered more favorable than individual biomarker to diagnose hepatocellular carcinoma (HCC). Based on age, sex, alpha-fetoprotein (AFP), and protein induced by vitamin K absence II (PIVKA-II) with/without AFP-L3, ASAP and GALAD models are potential diagnostic panels. The diagnostic performances of these two panels were compared relative to HCC detection among patients with various etiologies of chronic liver diseases (CLDs).</p><h3>Methods</h3><p>A multicenter case-control study recruited CLDs patients with and without HCC from 14 Chinese hospitals. The etiologies of CLDs included hepatitis B virus (HBV), hepatitis C virus (HCV), alcoholic liver disease (ALD), and nonalcoholic fatty liver disease (NAFLD). Using area under the receiver operating characteristic curve (AUC) values, the diagnostic performances of ASAP and GALAD models were compared to detect HCC among patients with various etiologies of CLDs.</p><h3>Results</h3><p>Among 248 HCC patients and 722 CLD controls, the ASAP model demonstrated the highest AUC (0.886) to detect HCC at any stage, outperforming the GALAD model (0.853, <em>P</em> = 0.001), as well as any individual biomarker (0.687-0.799, all <em>P</em> &lt; 0.001). In the subgroup analysis of various CLDs etiologies, the ASAP model outperformed the GALAD model to HCC independent of CLDs etiology. In addition, the ASAP model performed better in detecting early-stage (BCLC stage 0/A) HCC versus the GALAD model.</p><h3>Conclusions</h3><p>Despite using one less laboratory variable (AFP-L3), the ASAP model demonstrated better diagnostic performance than the GALAD model to detect all-stage HCC among patients with various etiologies of CLDs-related HCC.</p>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":"9 1","pages":""},"PeriodicalIF":3.3,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139072358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mesenteric adipose tissue B lymphocytes promote intestinal injury in severe acute pancreatitis by mediating enteric pyroptosis 肠系膜脂肪组织B淋巴细胞通过介导肠热亡促进重症急性胰腺炎肠损伤。
IF 3.3 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2023-11-24 DOI: 10.1016/j.hbpd.2023.11.006
Qing Huang, Jia-Wen Liu, Hai-Bin Dong, Zheng-Jie Wei, Jin-Zhe Liu, Yu-Tang Ren, Xuan Jiang, Bo Jiang
{"title":"Mesenteric adipose tissue B lymphocytes promote intestinal injury in severe acute pancreatitis by mediating enteric pyroptosis","authors":"Qing Huang,&nbsp;Jia-Wen Liu,&nbsp;Hai-Bin Dong,&nbsp;Zheng-Jie Wei,&nbsp;Jin-Zhe Liu,&nbsp;Yu-Tang Ren,&nbsp;Xuan Jiang,&nbsp;Bo Jiang","doi":"10.1016/j.hbpd.2023.11.006","DOIUrl":"10.1016/j.hbpd.2023.11.006","url":null,"abstract":"<div><h3>Background</h3><p>Visceral adipose tissue<span><span> (VAT) has been linked to the severe acute pancreatitis (SAP) prognosis, although the underlying mechanism remains unclear. It has been reported that pyroptosis worsens SAP. The present study aimed to verify whether mesenteric adipose tissue (MAT, a component of VAT) can cause secondary </span>intestinal injury through the pyroptotic pathway.</span></p></div><div><h3>Methods</h3><p>Thirty-six male Sprague Dawley (SD) rats were divided into six different groups. Twelve rats were randomly divided into the SAP and control groups. We monitored the changes of MAT and B lymphocytes infiltration<span> in MAT of SAP rats. Twelve SAP rats were injected with MAT B lymphocytes or phosphate buffer solution (PBS). The remaining twelve SAP rats were first injected with MAT B lymphocytes, and then with MCC950 (NLRP3 inhibitor) or PBS. We collected blood and tissue samples from pancreas, gut and MAT for analysis.</span></p></div><div><h3>Results</h3><p><span><span>Compared to the control rats, the SAP group showed inflammation in MAT, including higher expression of tumor necrosis factor (TNF-α) and interleukin-6 (IL-6), lower expression of IL-10, and histological changes. Flow cytometry analysis revealed B lymphocytes infiltration in MAT but not </span>T lymphocytes and macrophages. The SAP rats also exhibited intestinal injury, characterized by lower expression of zonula occludens-1 (ZO-1) and </span>occludin<span><span>, higher levels of lipopolysaccharide<span> and diamine oxidase, and pathological changes. The expression of </span></span>NLRP3<span> and n-GSDMD, which are responsible for pyroptosis, was increased in the intestine of SAP rats. The injection of MAT B lymphocytes into SAP rats exacerbated the inflammation in MAT. The upregulation of pyroptosis reduced tight junction in the intestine, which contributed to the SAP progression, including higher inflammatory indicators and worse histological changes. The administration of MCC950 to SAP + MAT B rats downregulated pyroptosis, which subsequently improved the intestinal barrier and ameliorated inflammatory response of SAP.</span></span></p></div><div><h3>Conclusions</h3><p>In SAP, MAT B lymphocytes aggravated local inflammation, and promoted the injury to the intestine through the enteric pyroptotic pathway.</p></div>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":"23 3","pages":"Pages 300-309"},"PeriodicalIF":3.3,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138500260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of biliary protein spectrum in gallstone patients with obesity and those with normal body weight 肥胖与体重正常的胆结石患者胆道蛋白谱的比较。
IF 3.3 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2023-11-24 DOI: 10.1016/j.hbpd.2023.11.007
Min-Zhi Chen , Ping Xie , Xiao-Chang Wu , Zhen-Hua Tan , Hai Qian , Zhi-Hong Ma , Xing Yao
{"title":"Comparison of biliary protein spectrum in gallstone patients with obesity and those with normal body weight","authors":"Min-Zhi Chen ,&nbsp;Ping Xie ,&nbsp;Xiao-Chang Wu ,&nbsp;Zhen-Hua Tan ,&nbsp;Hai Qian ,&nbsp;Zhi-Hong Ma ,&nbsp;Xing Yao","doi":"10.1016/j.hbpd.2023.11.007","DOIUrl":"10.1016/j.hbpd.2023.11.007","url":null,"abstract":"<div><h3>Background</h3><p>Obesity is a common public health<span> issue and is currently deemed a disease. Research has shown that the risk of gallstones<span> in individuals with obesity is elevated. This study aimed to explore the bile proteomics<span> differences between cholelithiasis patients with obesity and normal body weight.</span></span></span></p></div><div><h3>Methods</h3><p>Bile samples from 20 patients (10 with obesity and 10 with normal body weight) who underwent laparoscopic cholecystectomy<span> at our center were subjected to tandem mass tag labeling (TMT) and liquid chromatography-tandem mass spectrometry (LC-MS/MS), followed by further bioinformatic analysis.</span></p></div><div><h3>Results</h3><p>Among the differentially expressed proteins, 23 were upregulated and 67 were downregulated. Bioinformatic analysis indicated that these differentially expressed proteins were mainly involved in cell development, inflammatory responses, glycerolipid<span> metabolic processes, and protein activation cascades. In addition, the activity of the peroxisome proliferator-activated receptor (PPAR, a subfamily of nuclear receptors) signaling pathway was decreased in the Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Two downregulated proteins in the PPAR signaling pathway, APO A-I and APO A-II, were confirmed using enzyme-linked immunosorbent assay.</span></p></div><div><h3>Conclusions</h3><p>The PPAR signaling pathway may play a crucial role in the development of cholelithiasis among patients with obesity. Furthermore, biliary proteomics profiling of gallstones patients with obesity is revealed, providing a reference for future research.</p></div>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":"23 4","pages":"Pages 385-392"},"PeriodicalIF":3.3,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138471283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of ginseng-based Renshenguben oral solution for cancer-related fatigue among patients with advanced-stage hepatocellular carcinoma: A prospective multicenter cohort study 人参人参骨本口服液治疗晚期肝癌患者癌症相关性疲劳的疗效:一项前瞻性多中心队列研究
IF 3.3 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2023-11-21 DOI: 10.1016/j.hbpd.2023.11.004
Ming-Da Wang , Chen Yuan , Ke-Chun Wang , Nan-Ya Wang , Ying-Jian Liang , Hong Zhu , Xiang-Min Tong , Tian Yang
{"title":"Efficacy of ginseng-based Renshenguben oral solution for cancer-related fatigue among patients with advanced-stage hepatocellular carcinoma: A prospective multicenter cohort study","authors":"Ming-Da Wang ,&nbsp;Chen Yuan ,&nbsp;Ke-Chun Wang ,&nbsp;Nan-Ya Wang ,&nbsp;Ying-Jian Liang ,&nbsp;Hong Zhu ,&nbsp;Xiang-Min Tong ,&nbsp;Tian Yang","doi":"10.1016/j.hbpd.2023.11.004","DOIUrl":"10.1016/j.hbpd.2023.11.004","url":null,"abstract":"<div><h3>Background</h3><p><span><span>Cancer-related fatigue (CRF) is a common and debilitating symptom experienced by patients with advanced-stage cancer, especially those undergoing antitumor therapy. This study aimed to evaluate the efficacy and safety of Renshenguben (RSGB) oral solution, a ginseng-based </span>traditional Chinese medicine, in alleviating CRF </span>in patients with advanced hepatocellular carcinoma (HCC) receiving antitumor treatment.</p></div><div><h3>Methods</h3><p>In this prospective, open-label, controlled, multicenter study, patients with advanced HCC at BCLC stage C and a brief fatigue inventory (BFI) score of ≥ 4 were enrolled. Participants were assigned to the RSGB group (RSGB, 10 mL twice daily) or the control group (with supportive care). Primary and secondary endpoints were the change in multidimensional fatigue inventory (MFI) score, and BFI and functional assessment of cancer therapy-hepatobiliary (FACT-Hep) scores at weeks 4 and 8 after enrollment. Adverse events (AEs) and toxicities were assessed.</p></div><div><h3>Results</h3><p>A total of 409 participants were enrolled, with 206 assigned to the RSGB group. At week 4, there was a trend towards improvement, but the differences were not statistically significant. At week 8, the RSGB group exhibited a significantly lower MFI score (<em>P</em> &lt; 0.05) compared to the control group, indicating improved fatigue levels. Additionally, the RSGB group showed significantly greater decrease in BFI and FACT-Hep scores at week 8 (<em>P</em><span> &lt; 0.05). Subgroup analyses among patients receiving various antitumor treatments showed similar results. Multivariate linear regression analyses revealed that the RSGB group experienced a significantly substantial decrease in MFI, BFI, and FACT-Hep scores at week 8. No serious drug-related AEs or toxicities were observed.</span></p></div><div><h3>Conclusions</h3><p>RSGB oral solution effectively reduced CRF in patients with advanced HCC undergoing antitumor therapy over an eight-week period, with no discernible toxicities. These findings support the potential of RSGB oral solution as an adjunctive treatment for managing CRF in this patient population.</p></div>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":"23 3","pages":"Pages 249-256"},"PeriodicalIF":3.3,"publicationDate":"2023-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138471284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on “Robotic surgery and liver transplantation: A single-center experience of 501 robotic donor hepatectomies” 评论“机器人手术与肝移植:501例机器人供肝切除术的单中心经验”
IF 3.3 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2023-11-19 DOI: 10.1016/j.hbpd.2023.11.005
Xiang-Yan Liu , Yun-Yang Xu , Ze Xiang , Shu-Sen Zheng
{"title":"Comment on “Robotic surgery and liver transplantation: A single-center experience of 501 robotic donor hepatectomies”","authors":"Xiang-Yan Liu ,&nbsp;Yun-Yang Xu ,&nbsp;Ze Xiang ,&nbsp;Shu-Sen Zheng","doi":"10.1016/j.hbpd.2023.11.005","DOIUrl":"10.1016/j.hbpd.2023.11.005","url":null,"abstract":"","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":"23 1","pages":"Pages 109-110"},"PeriodicalIF":3.3,"publicationDate":"2023-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138441696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THANKS 谢谢
IF 3.3 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2023-11-07 DOI: 10.1016/S1499-3872(23)00201-1
{"title":"THANKS","authors":"","doi":"10.1016/S1499-3872(23)00201-1","DOIUrl":"https://doi.org/10.1016/S1499-3872(23)00201-1","url":null,"abstract":"","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":"22 6","pages":"Page I"},"PeriodicalIF":3.3,"publicationDate":"2023-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71731821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信